Curcumin conjugates induce apoptosis via a mitochondrion dependent pathway in MCF-7 and MDA-MB-231 cell lines

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5797-5804

  Singh, Durg Vijay ^a,c   Agarwal, Shikha ^a   Singh, Preeti ^b   Godbole, Madan Madhav ^b   Misra, Krishna ^b  

^a INDIAN INSTITUTE OF INFORMATION TECHNOLOGY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c CENTRAL UNIVERSITY OF SOUTH BIHAR   (India)

Author keywords

AIF; Apoptosis; Bax; Bcl2; Curcumin conjugates; Immunoflurscence; NF kB; Western blotting

Indexed keywords

CURCUMIN; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; DNA FRAGMENTATION; DRUG EFFECTS; HUMAN; MCF 7 CELL LINE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CURCUMIN; CYTOCHROMES C; DNA FRAGMENTATION; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 84890471845     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5797     Document Type: Article

References (55)

1. Aggarwal BB, Shishodia S (2004). Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann NY Acad Sci, 1030, 434-41.
2. Almeida LP, Cherubino APF Alves RJ, Dufosse L, Gloria MBA (2005). Separation and determination of the physicochemical characteristics of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Res Int, 38, 1039-44.
3. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007). Bioavailability of curcumin: problem and promises. Mol Pharm, 4, 807-18.
4. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl2 and Bclxl. Carcinogenesis, 23, 143-50.
5. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC (2000). Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochemistry, 345, 271-8.
6. Asa BG, Roberta AG (2008). Heart mitochondria: gates of life and death. Cardiovasc Res, 77, 334-43.
7. Atsumi T, Fujisawa S, Tonosaki K (2005). Relationship between intracellular ROS production and membrane mobility in curcumin and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis, 11, 236-42.
8. Barzegar A, Moosavi-Movahedi AA (2011). Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One, 6, 26012.
9. Bleicken S, Classen M, Padmavathi PV, et al (2010). Molecular details of Bax activation, oligomerization, and membrane insertion. J Biol Chem, 285, 6636-47.
10. Bursch W (2001). The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ, 8, 569-81.
11. Chen QY, Lu GH, Wu YQ, et al (2010). Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep, 23, 1285-92.
12. Chi S, Kitanaka C, Noguchi K (1999). Oncogenic ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene, 18, 2281-90.
13. Eck-Enriquez K, Kiefer TL, Spriggs LL, Hill SM (2000). Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat, 61, 229-39.
14. Fandy TE, Shankar S, Srivastava RK (2008). Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer, 7, 60.
15. Fang J, Lu J, Holmgren A (2005). Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem, 280, 25284-90.
16. Hail NJr, Lotan R (2000). Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl) retinamide-induced apoptosis. Cancer Epidemiol Biomarkers Prev, 9, 1293-301.
17. Hegde R, Srinivasula SM, Zhang Z, et al (2002). Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem, 277, 432-8.
18. Hsu YC, Weng HC, Shiurulin, Chien Y (2007) Curcuminoids- cellular uptake by human primary colon cancer cells As quantitated by a sensitive HPLC assay and its relation with the inhibition of proliferation and apoptosis. J Agric Food Chem, 55, 8213-22.
19. Hussain AR, Ahmed M, Al-Jomah NA, et al (2008). Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther, 7, 3318-29.
20. Ikan R (1991). Natural Products, A Laboratory Guide, 2nd ed.; Academic Press: New York.
21. Kagawa S, Pearson SA, Ji L, et al (2000). Binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Ther, 7, 75-9.
22. Kitanaka C, Namiki T, Noguchi K, et al (1997). Caspasedependent apoptosis of COS-7 cells induced by bax overexpression: differential effects of Bcl2 and Bclxl on bax-induced caspase activation and apoptosis. Oncogene, 15, 1763-72.
23. Kulikov AV, Shilov ES, Mufazalov IA, et al (2012). Cytochrome c: the Achilles' heel in apoptosis. Cell Mol Life Sci, 69, 1787-97.
24. Kumar S, Narain U, Tripathi S, Misra K (2001). Syntheses of curcumin bioconjugates and study of their antibacterial activities against â-Lactamase-Producing Microorganisms. Bioconjugate Chem, 12, 464-9.
25. Kunwar A, Jayakumar S, Srivastava AK, Priyadarsini KI (2012). Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis. Arch Toxicol, 86, 603-14.
26. Lao CD, Ruffin MT, Normolle D, et al (2006). Dose escalation of curcuminoids formulation. BMC Complement Altern Med, 6, 10.
27. Lesauskaite V, Ivanoviene L (2002). Programmed cell death: molecular mechanisms and detection. Medicina Kaunas, 38, 869-75.
28. Liang Y, Yan C, Schor NF (2001). Apoptosis in the absence of caspase-3. Oncogene, 20, 6570-8.
29. Mishra S, Kapoor N, Mubarak Ali A, et al (2005b). Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Radic Biol Med, 38, 1353-60.
30. Mishra S, Narian U, Mishra R, Misra K (2005a). Design development and synthesis of mixed bioconjugates of piperic acids-glycine, curcumin-glycine,/alanine and curcuminglycine -piperic acids and their antibacterial and antifungal properties. Bioorg Med Chem, 13, 1477-86.
31. Miyashita T, Reed JC (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-9.
32. Nunaez G, Benedict MA, Yuanmimg H, Inohara N (1998). Caspases: the proteases of the apoptotic pathway. Oncogene, 17, 3237-45.
33. Oberhammer F, Wilson JW, Dive C, et al (1993). Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J, 12, 3679-84.
34. Rashmi R, Kumar S, Karunagaran D (2005). Human colon cancer cells lacking bax resist curcumin-induced apoptosis and bax requirement is dispensable with ectopic expression of smac or downregulation of Bclxl. Carcinogenesis, 26, 713-23.
35. Rosse T, Olivier R, Monney L, et al (1998). Bcl2 prolongs cell survival after Bax-induced release of cytochrome C. Nature, 391, 496-9.
36. Rudy A, Anton NL, Barth N, et al (2008). Role of smac in cephalostatin-induced cell death. Cell Death Differ, 15, 1930-40.
37. Saraste A, Pulkki K (2000). Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res, 45, 528-37.
38. Shimizu S, Narita M, Tsujimoto Y (1999). Bcl2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483-7.
39. Shoba G, Joy D, Joseph T, et al (1998). Inffluence of piperine on pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64, 353-6.
40. Singh DV, Godbole MM, Misra K (2013). A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors. J Mol Mod, 19, 227-38.
41. Singh DV, Misra K (2009). Curcuminoids as inhibitors of thioredoxin reductase: a receptor based pharmacophore study with distance mapping of the active site. Bioinformation, 4, 187-92.
42. Strasser EM, Wessner B, Manhart N, Roth E (2005). The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells. Biochem Pharmacol, 70, 552-9.
43. Susin SA, Zamzami N, Castedo M, et al (1997). The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Exp Med, 186, 25-37.
44. Suzuki Y, Imai Y, Nakayama H, et al (2001). A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell, 8, 613-21.
45. Uddin S, Hussain AR, Manogaran PS, et al (2005). Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene, 24, 7022-30.
46. Walsh JG, Cullen SP, Sheridan C, et al (2008). Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci, 105, 12815-9.
47. Wang C, Youle RJ (2009). The role of mitochondria in apoptosis. Annu Rev Genet, 43, 95-118.
48. Westphal D, Dewson G, Czabotar PE, Kluck RM (2011). Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta, 1813, 521-31.
49. Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH Jr (2003). Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood, 102, 237-45.
50. Xiang J, Chao DT, Korsmeyer SJ (1996). BAX-induced cell death may not require interleukin 1 beta-converting enzymelike proteases. Proc Natl Acad Sci, 93, 14559-63.
51. Yang XH, Sladek TL, Liu X, et al (2001). Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res, 61, 348-54.
52. Youle RJ, Strasser A (2008). The Bcl2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 9, 47-59.
53. Yu LL, Wu JG, Dai N, Yu HG, Si JM (2011). Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol Rep, 26, 1197-203.
54. Zamzami N, Susin SA, Marchetti P, et al (1996). Mitochondrial control of nuclear apoptosis. J Exp Med, 18, 1533-44.
55. Ziegler U, Groscurth P (2004). Morphological features of cell death. News Physiol Sci, 19, 124-8.